BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34468949)

  • 61. PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.
    Piccardo A; Trimboli P; Foppiani L; Treglia G; Ferrarazzo G; Massollo M; Bottoni G; Giovanella L
    Rev Endocr Metab Disord; 2019 Mar; 20(1):47-64. PubMed ID: 30900067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.
    Kolodziej M; Saracyn M; Lubas A; Brodowska-Kania D; Mazurek A; Dziuk M; Dymus J; Kaminski G
    Nucl Med Rev Cent East Eur; 2021; 24(2):63-69. PubMed ID: 34382670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules?
    Dutta S; Thaha MA; Smith DM
    Ann R Coll Surg Engl; 2011 Jul; 93(5):361-4. PubMed ID: 21943458
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
    Vriens D; de Wilt JH; van der Wilt GJ; Netea-Maier RT; Oyen WJ; de Geus-Oei LF
    Cancer; 2011 Oct; 117(20):4582-94. PubMed ID: 21432844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
    Pak K; Kim SJ; Kim IJ; Kim BH; Kim SS; Jeon YK
    Endocr Relat Cancer; 2013 Aug; 20(4):R203-13. PubMed ID: 23722225
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology.
    Rago T; Scutari M; Santini F; Loiacono V; Piaggi P; Di Coscio G; Basolo F; Berti P; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5274-80. PubMed ID: 20810572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of Malignancy in FDG-Avid Thyroid Incidentalomas on PET/CT: A Prospective Study.
    Abdel-Halim CN; Rosenberg T; Bjørndal K; Madsen AR; Jakobsen J; Døssing H; Bay M; Thomassen A; Nielsen AL; Godballe C
    World J Surg; 2019 Oct; 43(10):2454-2458. PubMed ID: 31161354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
    Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
    Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
    Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Diagnostic efficacy of (18)F-FDG PET-CT for focal hypermetabolic thyroid nodules].
    Cheng Y; Wu P; Du F; Wu ZF; Liu HY; Hao XZ; Li SJ
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):759-763. PubMed ID: 29061020
    [No Abstract]   [Full Text] [Related]  

  • 76. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
    Kim M; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
    Thyroid; 2019 Feb; 29(2):216-221. PubMed ID: 30421654
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N; Dallaire J; Vallée É; Belzile M
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How to approach thyroid nodules with indeterminate cytology.
    Yoon JH; Kwak JY; Kim EK; Moon HJ; Kim MJ; Kim JY; Koo HR; Kim MH
    Ann Surg Oncol; 2010 Aug; 17(8):2147-55. PubMed ID: 20217250
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
    Nguyen TT; Lange NGE; Nielsen AL; Thomassen A; Døssing H; Godballe C; Rohde M
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2109-2117. PubMed ID: 29909471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.